CIPLA Surges by 5%; BSE HEALTHCARE Index Up 2.1%
March 13, 2020 12:18 PM

CIPLA share price has zoomed 5% and is presently trading at Rs 418.

Meanwhile, the BSE HEALTHCARE Index is at 12,579 (up 2.1%).

Among the top Gainers in the BSE HEALTHCARE Index today are CIPLA (up 5.1%) and ABBOTT INDIA (up 5.1%).

NATCO PHARMA (down 0.1%) and APOLLO HOSPITALS (down 0.5%) are among the top losers today.

Over the last one year, CIPLA has moved down from Rs 539 to Rs 418, registering a loss of Rs 121 (down 23.0%).

On the other hand, the BSE HEALTHCARE has moved down from 14,333 to 12,579, loss of 1,754 points (down 12.7%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 98.6%), J.B.CHEMICALS (up 56.7%) and DR. LAL PATHLABS LTD (up 48.6%).

What About the Benchmark Indices?

The BSE Sensex is at 33,350 (up 1.3%).

The top gainers among the BSE Sensex stocks today are SBI (up 12.7%), SUN PHARMA (up 8.1%) and HDFC (up 5.9%). Other gainers include TATA STEEL (up 4.6%) and MARUTI SUZUKI (up 4.1%). The most traded stocks in the BSE Sensex are SBI and HDFC BANK.

In the meantime, NSE Nifty is at 9,750 (up 1.2%). SBI (up 11.7%) and SUN PHARMA (up 7.9%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 37,536 to 33,350, registering a loss of 4,186 points (down 11.5%).

CIPLA Financial Update...

CIPLA net profit stood at Rs 4 billion for the quarter ended December 2019, compared to a profit of Rs 3 billion a year ago. Net Sales rose 9.1% to Rs 43.7 billion during the period as against Rs 40.1 billion in October-December 2018.

For the year ended March 2019, CIPLA reported 0.9% increase in net profit to Rs 15.1 billion compared to net profit of Rs 15.0 billion during FY18.

Revenue of the company grew 8.3% to Rs 160 billion during FY19.

The current Price to earnings ratio of CIPLA, based on rolling 12 month earnings, stands at 19.9x.